Heart failure | BJC TV

Protected: Rapid up-titration of heart failure therapies: practice strategies for adopting a STRONG-HF pathway in the UK

2 December 2025

Sponsored

Rajiv Sankaranarayanan, Consultant Cardiologist, University Hospitals Liverpool is joined by Parin Shah, Consultant Cardiologist, Swansea Bay University Health Board and Matthew Sunter, Lead Heart Failure Nurse, St. George's University Hospital, London as they share how they’ve implemented and adapted the STRONG-HF¹ pathway to improve heart failure care. They discuss early patient identification, rapid optimisation, and collaborative follow-up models tailored to local needs. Through shared learning and teamwork across disciplines, each centre has refined its approach to deliver more efficient, patient-centred heart failure management.

MC-UK-01533 | December 2025

Prescribing to reduce further events in chronic coronary syndrome and cardiac failure

15 January 2025

Gayle Campbell and Professor Pardeep Jhund discuss secondary prevention for heart failure patients, including key topics such as preventing reinfarction, foundational anti-failure agents, managing worsening heart failure, and improving patient adherence using tools like MedTap.

ESC Congress 2024 highlights – A UK perspective: What’s new in the latest ESC guideline update?

12 December 2024

Dr Paul Foley and Prof Terry McCormack share the key changes in the new ESC guidance on atrial fibrillation, hypertension and arterial disease.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

ESC Congress 2024 highlights – A UK perspective: New evidence on cardiovascular medical care

12 December 2024

Dr Sarah Birkhoelzer and Dr Aaron Henry discuss hot topics and late-breaking abstracts from across the congress.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

Masterclass: Digoxin, heart failure and the elderly

27 March 2024

Join Professor Chim Lang and Dr Su-Lee Xiao as they discuss the role that digoxin still has to play in heart failure management and what to look out for when treating high-risk patients.

Masterclass: Lipids – the good, the bad and the ugly

23 January 2024

Watch Dermot Neely and Paul Hamilton discuss the different biological lipid transport pathways, how we measure lipids in the blood and how to distinguish between beneficial and non-beneficial lipids, and the national guidelines for lipid management in primary and secondary prevention of cardiovascular disease.